FindTrial
Sign In

Nanogam 100 mg/ml oplossing voor infusie

DRUG2 trials

Sponsors

Universitair Medisch Centrum Utrecht, Stichting Amsterdam UMC

Conditions

Idiopathic inflammatory myopathyPrimary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)

Phase 2

Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial
Active, not recruitingCTIS2024-516057-42-00
Stichting Amsterdam UMCIdiopathic inflammatory myopathy
Start: 2024-10-10Target: 48Updated: 2024-10-10

Phase 3

Influencing Progression of Airway Disease in Primary Antibody Deficiency
Not yet recruitingCTIS2024-513124-41-00
Universitair Medisch Centrum UtrechtPrimary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)
Target: 100Updated: 2024-07-12